Ultrasound-Based Diagnostic Methods: Possible Use in Fatty Liver Disease Area

Area of Science:

• Hepatology
• Medical Imaging
• Diagnostic Ultrasound

Background:

• Liver steatosis (fatty liver disease) is a growing global health concern linked to metabolic syndrome and advanced liver disease.
• Non-alcoholic fatty liver disease (NAFLD) is a leading cause of liver cirrhosis, highlighting the need for effective monitoring.
• The interplay between liver steatosis, fibrosis, and metabolic factors necessitates accurate diagnostic tools.

Purpose of the Study:

• To review the reliability and application of advanced ultrasound techniques for quantitatively assessing liver steatosis.
• To explore the potential of these ultrasound methods in evaluating NAFLD's impact on liver fibrosis progression.
• To assess the utility of ultrasound in monitoring metabolic risk factors and complications associated with NAFLD.

Main Methods:

• Review of recent technological advancements in ultrasound-based quantitative assessment of liver steatosis.
• Analysis of studies comparing ultrasound methods (attenuation parameters, backscatter coefficients, envelope statistics) with reference standards (biopsy, MRI).
• Evaluation of research on the role of ultrasound in diagnosing and monitoring NAFLD and its progression.

Main Results:

• Ultrasound-based methods demonstrate favorable diagnostic accuracy (positive and negative predictive values) for liver steatosis compared to biopsy and MRI.
• These techniques are accessible, cost-effective, and well-tolerated by patients.
• Emerging evidence supports their use in assessing NAFLD's influence on liver fibrosis, metabolic health, and cardiovascular risks.

Conclusions:

• Advanced ultrasound techniques provide a reliable, non-invasive means for quantitative assessment of liver steatosis.
• These methods hold significant potential for monitoring NAFLD progression, liver fibrosis, and associated systemic complications.
• Ultrasound offers a valuable tool for managing patients with fatty liver disease and its comorbidities.